Basic Concept of Prodrugs

Basic Concept of Prodrugs explains inactive drug forms that convert into active drugs in the body to improve absorption and bioavailability.

Basic Concept of Prodrugs

  • Prodrugs are inactive or less active precursors that convert into active drugs in the body, addressing issues like poor bioavailability, short half-life, or high toxicity.

Ideal Properties of Prodrugs

  1. Biologically inactive or less active: Minimizes side effects before activation.
  2. Efficient conversion: Easily metabolized into the active drug.
  3. Targeted delivery: Reduces off-target effects.
  4. Improved pharmacokinetics: Enhances drug absorption and metabolism.
  5. Non-toxic and non-immunogenic: Safe for use.
Advertisements

Introduction to Prodrugs

  • Prodrugs are biologically inactive compounds that undergo metabolic conversion in the body to release the active drug.
  • They are designed to improve solubility, stability, absorption, distribution, metabolism, and elimination while maintaining therapeutic efficacy.

Objectives of Prodrug Development

  1. Improved solubility and absorption: Enhances bioavailability of poorly soluble drugs.
  2. Enhanced drug delivery: Targets specific tissues, reducing side effects.
  3. Reduced toxicity and side effects: Minimizes adverse effects until activation.
  4. Bypassing first-pass metabolism: Increases systemic drug availability.
  5. Prolonged duration of action: Provides sustained therapeutic effects.

Classification of Prodrugs

Classification of Prodrugs

Advertisements
  1. Bioprecursor Prodrugs:

    • Converted into the active drug via metabolic processes.
      • Type I: Modified via oxidation/reduction (e.g., Codeine → Morphine).
      • Type II: Structural rearrangement (e.g., Fosphenytoin → Phenytoin).
      • Type III: Combination of modifications (e.g., Prontosil → Sulfanilamide).
  2. Carrier-Linked Prodrugs:

    • Active drug is linked to a carrier, removed enzymatically.
      • Type A: Direct chemical bond (e.g., Aspirin → Salicylic acid).
      • Type B: Spacer group is cleaved (e.g., Valacyclovir → Acyclovir).
      • Type C: Carrier has therapeutic activity (e.g., 5-FU + Leucovorin).

Applications of Prodrugs

  1. Improved solubility and absorption: Fosamprenavir enhances oral bioavailability.
  2. Enhanced drug delivery: Capecitabine targets tumors.
  3. Reduced toxicity and side effects: Prednisolone phosphate minimizes GI irritation.
  4. Bypassing first-pass metabolism: Lisdexamfetamine avoids liver metabolism.
  5. Prolonged duration of action: Latanoprost provides sustained glaucoma treatment.
  6. Improved patient compliance: Oseltamivir phosphate has better taste and stability.
  7. Overcoming drug resistance: Tenofovir alafenamide achieves higher intracellular drug levels.

Click Here to Watch the Best Pharma Videos

Advertisements

Leave a Comment

This site uses Akismet to reduce spam. Learn how your comment data is processed.